GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (NAS:DXCM) » Definitions » E10

DXCM (DexCom) E10 : $0.49 (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is DexCom E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

DexCom's adjusted earnings per share data for the three months ended in Dec. 2024 was $0.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.49 for the trailing ten years ended in Dec. 2024.

During the past 12 months, DexCom's average E10 Growth Rate was 48.50% per year. During the past 3 years, the average E10 Growth Rate was 91.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of DexCom was 91.30% per year. The lowest was 8.80% per year. And the median was 14.80% per year.

As of today (2025-03-15), DexCom's current stock price is $70.69. DexCom's E10 for the quarter that ended in Dec. 2024 was $0.49. DexCom's Shiller PE Ratio of today is 144.27.

During the past 13 years, the highest Shiller PE Ratio of DexCom was 5379.50. The lowest was 138.57. And the median was 608.50.


DexCom E10 Historical Data

The historical data trend for DexCom's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom E10 Chart

DexCom Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.07 0.18 0.33 0.49

DexCom Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.38 0.42 0.46 0.49

Competitive Comparison of DexCom's E10

For the Medical Devices subindustry, DexCom's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where DexCom's Shiller PE Ratio falls into.



DexCom E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DexCom's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.38/133.1571*133.1571
=0.380

Current CPI (Dec. 2024) = 133.1571.

DexCom Quarterly Data

per share eps CPI Adj_EPS
201503 -0.043 99.621 -0.057
201506 -0.013 100.684 -0.017
201509 -0.133 100.392 -0.176
201512 0.005 99.792 0.007
201603 -0.058 100.470 -0.077
201606 -0.060 101.688 -0.079
201609 -0.055 101.861 -0.072
201612 -0.023 101.863 -0.030
201703 -0.123 102.862 -0.159
201706 0.008 103.349 0.010
201709 -0.005 104.136 -0.006
201712 -0.028 104.011 -0.036
201803 -0.070 105.290 -0.089
201806 0.085 106.317 0.106
201809 0.130 106.507 0.163
201812 -0.508 105.998 -0.638
201903 -0.075 107.251 -0.093
201906 -0.030 108.070 -0.037
201909 0.125 108.329 0.154
201912 0.250 108.420 0.307
202003 0.053 108.902 0.065
202006 0.120 108.767 0.147
202009 0.183 109.815 0.222
202012 0.908 109.897 1.100
202103 0.140 111.754 0.167
202106 0.190 114.631 0.221
202109 0.210 115.734 0.242
202112 -0.050 117.630 -0.057
202203 0.230 121.301 0.252
202206 0.120 125.017 0.128
202209 0.240 125.227 0.255
202212 0.220 125.222 0.234
202303 0.120 127.348 0.125
202306 0.280 128.729 0.290
202309 0.290 129.860 0.297
202312 0.620 129.419 0.638
202403 0.360 131.776 0.364
202406 0.350 132.554 0.352
202409 0.340 133.029 0.340
202412 0.380 133.157 0.380

Add all the adjusted EPS together and divide 10 will get our e10.


DexCom  (NAS:DXCM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

DexCom's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=70.69/0.49
=144.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of DexCom was 5379.50. The lowest was 138.57. And the median was 608.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


DexCom E10 Related Terms

Thank you for viewing the detailed overview of DexCom's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Executives
Matthew Vincent Dolan officer: * 6340 SEQUENCE DR, SAN DIEGO CA 92121
Sadie Stern officer: Chief Human Resources Officer 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Jacob Steven Leach officer: SVP, Research & Development 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Jereme M Sylvain officer: SVP, Finance & CAO 6340 SEQUENCE DRIVE, SAN DIEGO X1 92121
Kevin R Sayer director
Bridgette P Heller director TECH DATA CORPORATION, 5350 TECH DATA DRIVE, CLEARWATER FL 33760
Micheal Jon Brown officer: EVP, Chief Legal Officer 6340 SEQUENCE DR, SAN DIEGO CA 92121
Mark G Foletta director AMYLIN PHARMACEUTICALS INC, 9360 TOWNE CENTRE DR, SAN DIEGO CA 92121
Teri L Lawver officer: EVP Chief Commercial Officer C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Steven R Altman director
Nicholas Augustinos director 754 GRAND VIEW AVENUE, SAN FRANCISCO CA 94114
Steven Robert Pacelli officer: Vice President Legal Affairs 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Girish Naganathan officer: EVP Chief Technology Officer C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Barry J. Regan officer: EVP Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Rimma Driscoll director C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054